The evolving role of ctDNA in colorectal cancer: guidance of adjuvant therapy or surveillance strategies?

By afschroeder • February 13, 2026

Barrett LG, Gangi A, Hendifar A, Osipov A, Atkins K, Zaghiyan K, Nasseri Y, Murrell Z, Waters K, Mehta P, Zell JA, Hitchins MP, Gong J. The evolving role of ctDNA in colorectal cancer: guidance of adjuvant therapy or surveillance strategies? Transl Gastroenterol Hepatol. 2026 Jan 23;11:2. doi: 10.21037/tgh-25-75. PMID: 41675310; PMCID: PMC12887280.

Tags: adjuvant chemotherapy (ACT), Cedars Sinai DoM, circulating tumor DNA (ctDNA), Colon cancer, Hematology/Oncology, minimal residual disease (MRD), Publications

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial

McDonald CM, Villa C, Soslow JH, Maharry K, Hogan N, Binks M, Berth KC, Elliott KA, Taylor M, Hor KN, Signorovich J, Henricson EK, Phan[...]

Hidden risk in normal myocardial perfusion scans: AI-detected proximal coronary calcium on CT attenuation maps improves prognosis

Zhou J, Miller RJH, Shanbhag A, Killekar A, Han D, Patel KK, Pieszko K, Yi J, Urs MK, Ramirez G, Lemley M, Kavanagh PB, Liang[...]

Correction to: Consensus and Controversies about Diagnosing GH deficiency – A Delphi Survey by the GH Research Society

Radovick S, Arlien-Søborg MC, Boguszewski MCS, Bidlingmaier M, Johannsson G, Grimberg A, Ho KKY, Biller BMK, Choong CS, Hoffman AR, Backeljauw P, Boguszewski CL, Bollerslev[...]